Innovative cancer therapeutics
Biosight has raised €28M across 2 funding rounds from 4 investors, most recently a Series C round in Nov 2020. Based in Karmiel, Israel; founded 1999; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-11-03 | Series C | €16M | Israel Biotech Fund | View deal → |
| 2016-05-01 | Growth/Late | €12M | Arkin Holdings,Michael Ilan Management and Investments,Primera Capital | View deal → |
